Nadia Rosenthal

Nadia Rosenthal serves as Scientific Director of The Jackson Laboratory in Bar Harbor, Maine, and holds a Professorial Chair in Cardiovascular Sciences at Imperial College London. Her career includes directing a biomedical research laboratory at Harvard Medical School, heading the European Molecular Biology Laboratory (EMBL) campus in Rome, founding EMBL Australia as Chief Scientist, and establishing the Australian Regenerative Medicine Institute in Melbourne as its founding director.

She earned her PhD from Harvard Medical School, forming the foundation of her research trajectory in molecular biology and regenerative medicine. Her academic journey spans multiple international institutions with leadership roles in major research organizations.

Professor Rosenthal's research centers on regenerative medicine mechanisms, specifically investigating how growth factors, stromal cells, and immune system interactions resolve tissue damage. Her team pioneered methods to modify immune cell infiltration profiles to control tissue repair processes and leveraged mouse genetic diversity to uncover novel pathways in cardiovascular disease response variability. Since 2019, they have developed precision mouse models for SARS-CoV-2 research, demonstrating cross-disciplinary applications of mouse genetics in infectious disease modeling.

Her scientific recognition includes:

• EMBO Fellowship
• Fellowship in the UK Academy of Medical Sciences
• Fellowship in the Australian Academy of Health and Medical Sciences

She leads a research team at The Jackson Laboratory focused on translating fundamental discoveries in tissue regeneration into clinical applications, with particular emphasis on cardiovascular pathologies and immune modulation strategies. Her work bridges basic science and translational medicine through innovative genetic approaches.